CNS: financial statements from SEC — TradeAlmanac

CNS

Cohen & Steers Inc: financial statements

Company reports as filed with the U.S. Securities and Exchange Commission.

AnnualQuarterly

Income statement

Metric	Mar 31, 2026	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Sep 30, 2024	Jun 30, 2024
Revenue	146m	142m	136m	134m	133m	122m
Selling, general and administrative	19m	17m	18m	17m	15m	15m
Operating expenses	96m	93m	93m	89m	88m	83m
Operating income	50m	49m	43m	45m	45m	38m
Pre-tax income	57m	56m	54m	53m	68m	41m
Income tax	—	—	—	—	12m	11m
Net income	42m	42m	37m	40m	40m	32m
Earnings per share	0.82	0.81	0.72	0.78	0.78	0.63
Earnings per share, diluted	0.82	0.81	0.72	0.77	0.77	0.63
Weighted average shares	51m	51m	51m	51m	51m	50m
Weighted average shares, diluted	52m	52m	51m	51m	51m	51m

Balance sheet

Metric	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024
Cash and equivalents	53m	145m	98m	95m	65m	183m	106m	122m
Receivables	—	80m

Cash flow

Metric	Mar 31, 2026	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Sep 30, 2024	Jun 30, 2024
Operating cash flow	−51m	—	—	−109m	—	—
Depreciation and amortisation	3m	3m	2m	2m

Amounts in USD unless stated otherwise. Sources: Nasdaq Trader, Yahoo Finance, U.S. Securities and Exchange Commission (EDGAR)